Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Supplementation in Women With DCIS and/or LCIS
NCT02936999Phase 1Terminated
- Sponsor
- Inova Health System
- Start
- Aug 2016
- Primary completion
- Jan 2019
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of vitamin d in ductal carcinoma in situ (DCIS) and lobular carcinoma in situ (LCIS), sponsored by Inova Health System. Primary endpoint: Ki-67 Proliferative Index at 28 days. Started Aug 2016; status: terminated.
02
Drugs
vitamin d
03
Conditions
ductal carcinoma in situ (DCIS)lobular carcinoma in situ (LCIS)
Beyond the preview
Go deeper on NCT02936999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02936999.